OFIX

Orthofix Medical Inc

Add to Watchlist

Advanced Chart

14.510

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

14.510

Open

14.510

VWAP

14.51

Vol

2.05K

Mkt Cap

573.06M

Low

14.510

Amount

29.73K

EV/EBITDA(TTM)

20.12

Total Shares

37.53M

682.75M

EV/OCF(TTM)

23.83

P/S(TTM)

0.70

Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

200.86M

+3.72%

221.02M

+2.49%

200.16M

+1.81%

Estimates Revision

The market is revising Downward the revenue expectations for Orthofix Medical Inc. (OFIX) for FY2025, with the revenue forecasts being adjusted by -0.14% over the past three months. During the same period, the stock price has changed by 20.32%.

Revenue Estimates for FY2025

Revise Downward

-0.14%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+66.67%

In Past 3 Month

Stock Price

Go Up

+20.32%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast OFIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OFIX is 21.00 USD with a low forecast of 17.00 USD and a high forecast of 24.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 14.510

Low

17.00

Averages

21.00

High

24.00

Current: 14.510

Low

17.00

Averages

21.00

High

24.00

Barrington

Michael Petusky

Outperform

maintain

$16 -> $17

2025-08-06

Reason

Barrington

Michael Petusky

Price Target

$16 -> $17

2025-08-06

maintain

Outperform

Reason

Barrington analyst Michael Petusky raised the firm's price target on Orthofix to $17 from $16 and keeps an Outperform rating on the shares. The company reported strong Q2 results and affirmed its fiscal 2025 outlook, the analyst tells investors in a research note.

Barrington

Michael Petusky

Outperform

initiated

$16

2025-06-23

Reason

Barrington

Michael Petusky

Price Target

$16

2025-06-23

initiated

Outperform

Reason

Barrington analyst Michael Petusky initiated coverage of Orthofix with an Outperform rating and $16 price target. Orthofix is a medical technology company which operates through two reportable business segments: global spine and global orthopedics, the analyst tells investors in a research note. The firm says the company competes in spaces within medical technology that are "sizable and should demonstrate solid organic growth over the next several years." It believes multiple expansion is likely if Orthofix begins to consistently execute against its strategic vision.

Roth MKM

Jason Wittes

Strong Buy

Reiterates

$22

2025-02-26

Reason

Roth MKM

Jason Wittes

Price Target

$22

2025-02-26

Reiterates

Strong Buy

Reason

Canaccord Genuity

Caitlin Burrows

Strong Buy

Maintains

$24

2025-02-26

Reason

Canaccord Genuity

Caitlin Burrows

Price Target

$24

2025-02-26

Maintains

Strong Buy

Reason

Canaccord Genuity

Caitlin Burrows

Strong Buy

Initiates

$24

2025-01-22

Reason

Canaccord Genuity

Caitlin Burrows

Price Target

$24

2025-01-22

Initiates

Strong Buy

Reason

Stifel

Mathew Blackman

Hold

Strong Buy

Upgrades

$18 → $24

2024-11-08

Reason

Stifel

Mathew Blackman

Price Target

$18 → $24

2024-11-08

Upgrades

Hold

Strong Buy

Reason

Stifel upgraded Orthofix to Buy from Hold with a price target of $24, up from $18.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Orthofix Medical Inc (OFIX.O) is -8.47, compared to its 5-year average forward P/E of -4.18. For a more detailed relative valuation and DCF analysis to assess Orthofix Medical Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-4.18

Current PE

-8.47

Overvalued PE

102.46

Undervalued PE

-110.82

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

10.21

Current EV/EBITDA

7.98

Overvalued EV/EBITDA

13.12

Undervalued EV/EBITDA

7.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.03

Current PS

0.67

Overvalued PS

1.46

Undervalued PS

0.60